Skip to main content

Table 4 Specific treatment of pandemic and postpandemic patients during their stay in ICU

From: ICU-treated influenza A(H1N1) pdm09 infections more severe post pandemic than during 2009 pandemic: a retrospective analysis

Variables

2009–2010

Pandemic (n = 16)

2012–2016

Postpandemic (n = 60)

p value

Invasive ventilation

8 (50)

37 (61.7)

0.40

Noninvasive ventilation

9 (56)

42 (70)

0.37

Vasopressor treatment

5 (31)

38 (63.3)

0.03

Renal replacement therapy

1 (6.3)

11 (18.3)

0.44

Duration of invasive ventilation, hours

36.7 (17.5–176.5)

114 (24–193.5)

0.43

Duration of noninvasive ventilation, hours

16 (15–42)

27.7 (7.8–53.6)

0.45

ECMO

0

4 (6.7)

0.57

SOFA circulation

  

0.042

 0 points

3 (18.8)

3 (5.0)

 

 1 point

8 (50.0)

19 (31.7)

 

 2 points

0

0

 

 3 points

1 (6.3)

16 (26.7)

 

 4 points

4 (25.0)

22 (36.7)

 

SOFA respiratory

  

0.38

 0 points

1 (6.3)

1 (1.7)

 

 1 point

1 (6.3)

7 (11.7)

 

 2 points

6 (37.5)

12 (20.0)

 

 3 points

3 (18.8)

16 (26.7)

 

 4 points

5 (31.3)

24 (40.0)

 
  1. ECMO extracorporeal membrane oxygenation, ICU intensive care unit, SOFA Sequential Organ Failure Assessment
  2. Values are presented as median (25th–75th percentile) or as number (percentage) of patients